Asda

Legends Global, formerly known as ASM Global, exists to solve the complex challenges that venues face in today's competitive entertainment landscape. Every year, the company manages over 400 premier venues worldwide, hosting 20,000 events and entertaining 165 million guests across stadiums, arenas, convention centers, and theaters. The company delivers a fully integrated solution that helps partners build their vision, monetize their business, and operate enhanced experiences for every guest through premium services including feasibility & consulting, owner's representation, sales, partnerships, hospitality, merchandise, venue management, and content & booking. In 2024, ASM Global joined forces with Legends to create Legends Global, uniting two industry leaders to redefine live experiences across venues, sports, and entertainment globally. The company specializes in crafting unforgettable experiences that keep the spotlight on partners, collaborating behind the scenes with premium services to defeat unique challenges with innovative solutions. Their approach is rooted in respect, ambitious thinking, collaboration, and bold action, creating an inclusive workplace where team members can be authentic, make an impact, and grow their careers.

In 1999, two science-based companies with shared visions came together to form AstraZeneca: Sweden's Astra AB and the UK's Zeneca Group PLC. This strategic merger combined decades of pharmaceutical expertise, creating a global powerhouse uniquely positioned to push the boundaries of scientific discovery. What began as a union of strengths has evolved into a relentless pursuit of breakthrough therapies, with the company investing billions annually in research and development to transform patient outcomes across oncology, biopharmaceuticals, respiratory, and rare diseases. Today, AstraZeneca stands at the forefront of precision medicine and next-generation therapeutics, harnessing the power of data science, AI, and innovative technologies like cell therapies. With 197 projects in the pipeline and 16 blockbuster medicines, the company operates from six strategic R&D centres spanning Cambridge, Gothenburg, Gaithersburg, Boston, Shanghai, and Beijing. Their bold aspiration to deliver 20 new medicines by 2030 reflects an unwavering commitment to following the science and putting patients first - values that have driven every decision since that pivotal merger more than two decades ago.

ISCC is a globally applicable and leading certification system designed to enhance traceable, sustainable, deforestation-free, and climate-friendly supply chains. The organization empowers companies and stakeholders across industries to build sustainable supply chains through trusted and comprehensive certification solutions. ISCC operates as an independent multi-stakeholder initiative and certification system, covering all sustainable feedstocks including agricultural and forestry biomass. ISCC certifies the transition to alternative energy and provides sustainable solutions for traceable and deforestation-free supply chains. The certification system is recognized by regulatory bodies including the European Commission for sustainable fuels and electricity production. With multiple certification schemes such as ISCC EU, ISCC PLUS, and ISCC CORSIA, the organization addresses diverse markets including biofuels, food and feed, plastics and packaging, textiles, and circular economy sectors. ISCC's global presence spans multiple continents with stakeholder committees and operations worldwide.

We're the team behind the machines that make the chips powering everything from your smartphone to medical devices. Our lithography systems help chipmakers mass produce patterns on silicon, making chips smaller, faster and more energy efficient. Since starting in 1984 in a leaky shed in the Netherlands, we've grown into a global team of over 40,000 people across 60 locations in 16 countries, all working together to push technology to its limits. What we do is complex - our EUV lithography machines are among the most sophisticated ever built - but our mission is straightforward: we provide chipmakers with everything they need - hardware, software and services - to manufacture the microchips that drive modern life. We're proud that the world's top chip companies trust our machines, and that chances are you're using technology made with our help every single day.

Amgen is a worldwide pioneer in biotechnology, harnessing the best of biology and technology to fight the world's toughest diseases. Founded in 1980 in Thousand Oaks, California, Amgen has grown from a pioneering biotech startup with just a handful of employees into one of the world's leading independent biotechnology companies. For over 45 years, Amgen has been committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. The company's reach extends to millions of patients globally, transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. As an American multinational biopharmaceutical company, Amgen focuses on four key therapeutic areas: cardiovascular metabolic, bone health, inflammation, and oncology. The company's robust pipeline leverages state-of-the-art science and molecular engineering, pursuing transformative medicines with large effects. Amgen's commitment to patients is matched by its investment in its workforce, offering comprehensive benefits that support work-life balance, health, and career growth. With operations spanning the globe and a mission to make people's lives easier, fuller, and longer, Amgen continues to push the boundaries of what's possible in biotechnology and medicine.

In 1999, Matthieu Courtecuisse founded Sia with a vision that would redefine management consulting for the digital age. While traditional consulting firms were built on legacy models, Sia was 'born digital' - a deliberate choice to create a new kind of consulting group that could help organizations navigate unprecedented technological change. From its origins in France, the company recognized early on that the digital revolution would require more than just strategy; it would demand a fundamental rethinking of how businesses transform. Over the past two decades, Sia has evolved into a global force with 3,000 consultants across 48 offices in 19 countries, pioneering what they call 'Consulting 4.0' - an approach that augments traditional consulting with data science, creativity, and artificial intelligence. Today, Sia's mission has crystallized around being 'optimists for change,' reflecting their core belief that successful transformation requires both technical expertise and a fundamentally positive outlook on what businesses can achieve. The firm's comprehensive ecosystem includes strategy and management consulting, AI solutions through Heka, experience design via SiaXperience, specialized life sciences consulting through Sia/LBG, and leadership coaching through Uside. Their 'Consulting for Good' initiative demonstrates a commitment to being purpose-driven, integrating corporate social responsibility across climate, social responsibility, and ethics. With approximately 1,000 blue-chip and big tech clients, Sia continues to prove that a consultancy born in the digital era can deliver superior value while helping clients not just navigate change, but benefit from it.